Clinical trial of Δ1-testololactone (NSC 23759), medroxy progesterone acetate (NSC 26386) and oxylone acetate (NSC 47438) in advanced female mammary cancer:A report of the cooperative breast cancer group (Q54253940)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Clinical trial of Δ1-testololactone (NSC 23759), medroxy progesterone acetate (NSC 26386) and oxylone acetate (NSC 47438) in advanced female mammary cancer:A report of the cooperative breast cancer group
scientific article

    Statements

    title
    Clinical trial of Δ1-testololactone (NSC 23759), medroxy progesterone acetate (NSC 26386) and oxylone acetate (NSC 47438) in advanced female mammary cancer:A report of the cooperative breast cancer group (English)
    reason for preferred rank
    most precise value
    1 reference
    stated in
    Crossref
    DOI
    10.1002/1097-0142(196901)23:1<109::AID-CNCR2820230112>3.0.CO;2-1
    reference URL
    https://api.crossref.org/works/10.1002/1097-0142(196901)23:1%3C109::AID-CNCR2820230112%3E3.0.CO;2-1
    retrieved
    14 March 2023
    Clinical trial of delta-1-testololactone (NSC 23759), medroxy progesterone acetate (NSC 26386) and oxylone acetate (NSC 47438) in advanced female mammary cancer. A report of the cooperative breast cancer group (English)
    1 reference
    stated in
    Europe PubMed Central
    PubMed publication ID
    4884063
    reference URL
    https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4884063
    retrieved
    14 March 2023

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit
                      Retrieved from "https://www.wikidata.org/w/index.php?title=Q54253940&oldid=1852111092"